Abbott Labs Posts Strong First-Quarter Growth
Abbott Labs reports higher earnings from continuing operations, as demand for its nutritional and diagnostic products offset declining sales of the company's medical devices.
Abbott Labs reports higher earnings from continuing operations, as demand for its nutritional and diagnostic products offset declining sales of the company's medical devices.
An Israel-based company plans to launch a device in January that uses motors and sensors to help paralyzed patients stand, walk and, in some cases, climb stairs, the Associated Press reported Thursday.
Allergan's Lap-Band, a device implanted in the stomach to limit the amount of food that can be ingested, is already on the market to help the very obese lose weight. But now the company hopes to win approval for less obese patients to use the band.
Medtronic, the world's largest medical device maker, reported fiscal first-quarter earnings Tuesday in line with Wall Street expectations, but weaker global demand for medical implants forced the company to slash 2011 earnings expectations.
The Food and Drug Administration is proposing to revamp its regulations of medical devices, the agency said Wednesday. While seeking to improve device safety, the FDA also wants to ease the regulatory environment and foster innovation. But the proposals have the industry concerned.
President Obama can't be pleased by the loss of a Democratic Senate seat which jeopardizes passage of his cherished health-care reform. The news, however, appears to have fueled a mini stock rally in the health-care and pharma sectors wary of how any reform would affect their businesses. The uptrend is expected to continue.






